BMS 270394

BMS 270394 is an agonist of retinoic acid receptor gamma (RARgamma, EC50 = 30 nM in a transactivation assay) and the active enantiomer of BMS 189961 (Cay-29380). It is selective for RARgamma over RARbeta (EC50 = 400 nM) and is inactive at RARalpha. BMS 270394 synergizes with paclitaxel (Cay-10461) to inhibit the growth of MCF-7 breast and OVCAR-3 ovarian cancer, as well as SqCC/Y1 head and neck squamous cell carcinoma, cells.Formal Name: 3-fluoro-4-[[(2R)-2-hydroxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)acetyl]amino]-benzoic acid. CAS Number: 262433-54-5. Molecular Formula: C23H26FNO4. Formula Weight: 399.5. Purity: >98%. Formulation: (Request formulation change), A solid. Solubility: DMSO: 20 mg/ml. SMILES: OC(C1=CC(F)=C(NC([C@H](O)C2=CC(C(C)(C)CCC3(C)C)=C3C=C2)=O)C=C1)=O. InChi Code: InChI=1S/C23H26FNO4/c1-22(2)9-10-23(3,4)16-11-13(5-7-15(16)22)19(26)20(27)25-18-8-6-14(21(28)29)12-17(18)24/h5-8,11-12,19,26H,9-10H2,1-4H3,(H,25,27)(H,28,29)/t19-/m1/s1. InChi Key: AANFHDFOMFRLLR-LJQANCHMSA-N.